|
1
|
Medema JP: Cancer stem cells: The
challenges ahead. Nat Cell Biol. 15:338–344. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beck B and Blanpain C: Unravelling cancer
stem cell potential. Nat Rev Cancer. 13:727–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li S and Li Q: Cancer stem cells and tumor
metastasis (Review). Int J Oncol. 44:1806–1812. 2014.PubMed/NCBI
|
|
4
|
Tang DG: Understanding cancer stem cell
heterogeneity and plasticity. Cell Res. 22:457–472. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Larzabal L, El-Nikhely N, Redrado M,
Seeger W, Savai R and Calvo A: Differential effects of drugs
targeting cancer stem cell (CSC) and non-CSC populations on lung
primary tumors and metastasis. PLoS One. 8:e797982013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar
|
|
7
|
Meng X, Li M, Wang X, Wang Y and Ma D:
Both CD133+ and CD133− subpopulations of A549
and H446 cells contain cancer-initiating cells. Cancer Sci.
100:1040–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cui F, Wang J, Chen D and Chen YJ: CD133
is a temporary marker of cancer stem cells in small cell lung
cancer, but not in non-small cell lung cancer. Oncol Rep.
25:701–708. 2011.
|
|
9
|
Akunuru S, James Zhai Q and Zheng Y:
Non-small cell lung cancer stem/progenitor cells are enriched in
multiple distinct phenotypic subpopulations and exhibit plasticity.
Cell Death Dis. 3:e3522012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tirino V, Desiderio V, Paino F, De Rosa A,
Papaccio F, La Noce M, Laino L, De Francesco F and Papaccio G:
Cancer stem cells in solid tumors: An overview and new approaches
for their isolation and characterization. FASEB J. 27:13–24. 2013.
View Article : Google Scholar
|
|
11
|
Roudi R, Madjd Z, Ebrahimi M, Samani FS
and Samadikuchaksaraei A: CD44 and CD24 cannot act as cancer stem
cell markers in human lung adenocarcinoma cell line A549. Cell Mol
Biol Lett. 19:23–36. 2014. View Article : Google Scholar
|
|
12
|
Wang L, Guo H, Lin C, Yang L and Wang X:
Enrichment and characterization of cancer stem like cells from a
cervical cancer cell line. Mol Med Rep. 9:2117–2123.
2014.PubMed/NCBI
|
|
13
|
Chen SF, Chang YC, Nieh S, Liu CL, Yang CY
and Lin YS: Nonadhesive culture system as a model of rapid sphere
formation with cancer stem cell properties. PLoS One. 7:e318642012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheng HH, Kuo CC, Yan JL, Chen HL, Lin WC,
Wang KH, Tsai KK, Guvén H, Flaberg E, Szekely L, et al: Control of
cyclooxygenase-2 expression and tumorigenesis by endogenous
5-methoxytryptophan. Proc Natl Acad Sci USA. 109:13231–13236. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Niero EL, Rocha-Sales B, Lauand C, Cortez
BA, de Souza MM, Rezende-Teixeira P, Urabayashi MS, Martens AA,
Neves JH and Machado-Santelli GM: The multiple facets of drug
resistance: One history, different approaches. J Exp Clin Cancer
Res. 33:372014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Di C and Zhao Y: Multiple drug resistance
due to resistance to stem cells and stem cell treatment progress in
cancer (Review). Exp Ther Med. 9:289–293. 2015.PubMed/NCBI
|
|
17
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tay Y, Zhang J, Thomson AM, Lim B and
Rigoutsos I: MicroRNAs to Nanog, Oct4 and Sox2 coding regions
modulate embryonic stem cell differentiation. Nature.
455:1124–1128. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakatsugawa M, Takahashi A, Hirohashi Y,
Torigoe T, Inoda S, Murase M, Asanuma H, Tamura Y, Morita R,
Michifuri Y, et al: SOX2 is overexpressed in stem-like cells of
human lung adenocarcinoma and augments the tumorigenicity. Lab
Invest. 91:1796–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Beltran AS, Rivenbark AG, Richardson BT,
Yuan X, Quian H, Hunt JP, Zimmerman E, Graves LM and Blancafort P:
Generation of tumor-initiating cells by exogenous delivery of OCT4
transcription factor. Breast Cancer Res. 13:R942011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ling GQ, Chen DB, Wang BQ and Zhang LS:
Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in
human breast cancer cell lines. Oncol Lett. 4:1264–1268.
2012.PubMed/NCBI
|
|
23
|
Liu H, Zhang W, Jia Y, Yu Q, Grau GE, Peng
L, Ran Y, Yang Z, Deng H and Lou J: Single-cell clones of liver
cancer stem cells have the potential of differentiating into
different types of tumor cells. Cell Death Dis. 4:e8572013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tirino V, Desiderio V, Paino F, Papaccio G
and De Rosa M: Methods for cancer stem cell detection and
isolation. Methods Mol Biol. 879:513–529. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y and Laterra J: Cancer stem cells:
Distinct entities or dynamically regulated phenotypes? Cancer Res.
72:576–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Plaks V, Kong N and Werb Z: The cancer
stem cell niche: How essential is the niche in regulating stemness
of tumor cells? Cell Stem Cell. 16:225–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Borovski T, De Sousa E Melo F, Vermeulen L
and Medema JP: Cancer stem cell niche: The place to be. Cancer Res.
71:634–639. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Twelves C, Chmielowska E, Havel L, Popat
S, Swieboda-Sadlej A, Sawrycki P, Bycott P, Ingrosso A, Kim S,
Williams JA, et al: Randomised phase II study of axitinib or
bevacizumab combined with paclitaxel/carboplatin as first-line
therapy for patients with advanced non-small-cell lung cancer. Ann
Oncol. 25:132–138. 2014. View Article : Google Scholar
|
|
29
|
Zakaria N, Yusoff NM, Zakaria Z, Lim MN,
Baharuddin PJ, Fakiruddin KS and Yahaya B: Human non-small cell
lung cancer expresses putative cancer stem cell markers and
exhibits the transcriptomic profile of multipotent cells. BMC
Cancer. 15:842015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu X, Chen H and Wang X: Can lung cancer
stem cells be targeted for therapies? Cancer Treat Rev. 38:580–588.
2012. View Article : Google Scholar : PubMed/NCBI
|
